TCT
<ѻý class="page-description">Transcatheter Cardiovascular Therapeuticsѻý>Larger CLEAR OASIS 9 trial could not replicate past results
Administration at first medical contact at PCI hospital tied to more spontaneous reperfusion
Stent-related events plateaued 6 months after DynamX implant
Larger pool of TAVR candidates suggested by EARLY TAVR trial results
Interventional cardiologists trained to handle His bundle recordings at one center
Outcome data still awaited after positive interim results
Additional patients in pivotal trial add to strength of the findings
TAVR, SAVR result in similar outcomes in female-dominated VIVA randomized trial
Study shows better-than-expected benefit for expanded criteria cohort
Pressure-controlled intermittent coronary sinus occlusion appears safe in acute MI, though
T-PASS trial weighs stopping aspirin within a month
Agent device avoids additional layer of stenting in patients with recurrent blockages
Improved limb salvage and primary patency possible with endovascular approach
Will preliminary results be confirmed by SUMMIT trial to come?
-
AHA: American Heart Association
November 2024
-
TCT: Transcatheter Cardiovascular Therapeutics
October 2024
-
HFSA: Heart Failure Society of America
September 2024
-
ESC: European Society of Cardiology Congress
August 2024